Biovail Corporation International today announced that Lundbeck’s Celexa has been approved for marketing by Health Canada’s Therapeutic Products Program (TPP) for the symptomatic relief of depression.

Biovail’s Canadian marketing division, Crystaal, will co-promote Celexa in collaboration with Lundbeck Canada Inc. Crystaal will promote Celexa to primary care physicians.
[more]

If you’re suffering from depression, CELEXA may be able to help you. CELEXA is an antidepressant (mood elevator) from the family of drugs known as selective serotonin reuptake inhibitors or SSRIs. CELEXA is commonly used to treat depression, as well as other conditions as determined by a doctor.
[more]